1.LRRK2 phosphorylates Snapin and inhibits interaction of Snapin with SNAP-25.
Hye Jin YUN ; Joohyun PARK ; Dong Hwan HO ; Heyjung KIM ; Cy Hyun KIM ; Hakjin OH ; Inhwa GA ; Hyemyung SEO ; Sunghoe CHANG ; Ilhong SON ; Wongi SEOL
Experimental & Molecular Medicine 2013;45(8):e36-
Leucine-rich repeat kinase 2 (LRRK2) is a gene that, upon mutation, causes autosomal-dominant familial Parkinson's disease (PD). Yeast two-hybrid screening revealed that Snapin, a SNAP-25 (synaptosomal-associated protein-25) interacting protein, interacts with LRRK2. An in vitro kinase assay exhibited that Snapin is phosphorylated by LRRK2. A glutathione-S-transferase (GST) pull-down assay showed that LRRK2 may interact with Snapin via its Ras-of-complex (ROC) and N-terminal domains, with no significant difference on interaction of Snapin with LRRK2 wild type (WT) or its pathogenic mutants. Further analysis by mutation study revealed that Threonine 117 of Snapin is one of the sites phosphorylated by LRRK2. Furthermore, a Snapin T117D phosphomimetic mutant decreased its interaction with SNAP-25 in the GST pull-down assay. SNAP-25 is a component of the SNARE (Soluble NSF Attachment protein REceptor) complex and is critical for the exocytosis of synaptic vesicles. Incubation of rat brain lysate with recombinant Snapin T117D, but not WT, protein caused decreased interaction of synaptotagmin with the SNARE complex based on a co-immunoprecipitation assay. We further found that LRRK2-dependent phosphorylation of Snapin in the hippocampal neurons resulted in a decrease in the number of readily releasable vesicles and the extent of exocytotic release. Combined, these data suggest that LRRK2 may regulate neurotransmitter release via control of Snapin function by inhibitory phosphorylation.
Amino Acid Sequence
;
Animals
;
Exocytosis
;
Female
;
HEK293 Cells
;
Humans
;
Mice
;
Molecular Sequence Data
;
Mutant Proteins/metabolism
;
Phosphorylation
;
Phosphothreonine/metabolism
;
Protein Binding
;
Protein Interaction Mapping
;
Protein Structure, Tertiary
;
Protein-Serine-Threonine Kinases/*metabolism
;
Qa-SNARE Proteins/metabolism
;
Rats
;
Rats, Sprague-Dawley
;
Synaptosomal-Associated Protein 25/*metabolism
;
Synaptotagmins/metabolism
;
Vesicle-Associated Membrane Protein 2/metabolism
;
Vesicular Transport Proteins/chemistry/*metabolism
2.Effects of Vam3 on sodium nitroprusside-induced apoptosis and SIRT1 and p53 expression in rat articular chondrocytes.
Ren-Tao JIANG ; Chun-Suo YAO ; Jin-Ye BAI ; Qi HOU
Acta Pharmaceutica Sinica 2014;49(5):608-614
This study is to investigate the effect of Vam3, a dimeric derivative of resveratrol, on SNP-induced apoptosis and its potential mechanism in rat articular chondrocytes. Isolated rat articular chondrocytes were treated with sodium nitroprusside (SNP), a NO donor, to induce apoptosis. Apoptosis percentage was evaluated by Annexin V-PI and nucleus fracture was examined by DAPI staining. Level of intracellular reactive oxygen species (ROS) was detected using 2, 7'-dichlorofluorescin diacetate (DCFH-DA) as a fluorescence probe by fluorescence microplate reader. The change in mitochondrial membrane potential was detected by TMRE staining. Expressions of SIRT1, acetylated p53 (ac-p53), cleaved caspase 9 and cleaved caspase 3 were determined by Western blotting. It showed that Vam3 up to 10 micromol x L(-1) could significantly reduce SNP-induced rat articular chondrocytes apoptosis (P < 0.01) and nucleus fracture, inhibit the increase of intracellular ROS level (P < 0.01) and reverse the decrease in mitochondrial membrane potential (P < 0.01). Simultaneously, Vam3 could upregulate the expression of SIRT1, deacetylate p53, and inhibit the cleavage of caspase 9 and caspase 3 (P < 0.01) of rat articular chondrocytes exposed to SNP. This study indicates Vam3 could protect rat articular chondrocytes against SNP-induced apoptosis, perhaps through the upregulation of SIRT1 and deacetylation of p53.
Animals
;
Apoptosis
;
drug effects
;
Arabidopsis Proteins
;
pharmacology
;
Cartilage, Articular
;
cytology
;
Caspase 3
;
metabolism
;
Caspase 9
;
metabolism
;
Cells, Cultured
;
Chondrocytes
;
cytology
;
metabolism
;
Male
;
Membrane Potential, Mitochondrial
;
drug effects
;
Nitric Oxide Donors
;
antagonists & inhibitors
;
pharmacology
;
Nitroprusside
;
pharmacology
;
Qa-SNARE Proteins
;
pharmacology
;
Rats
;
Rats, Wistar
;
Reactive Oxygen Species
;
metabolism
;
Sirtuin 1
;
metabolism
;
Tumor Suppressor Protein p53
;
metabolism
3.A Novel Syntaxin 11 Gene (STX11) Mutation c.650T>C, p.Leu217Pro, in a Korean Child With Familial Hemophagocytic Lymphohistiocytosis.
Ardak K SULTANOVA ; Seong Koo KIM ; Jae Wook LEE ; Pil Sang JANG ; Nack Gyun CHUNG ; Bin CHO ; Joonhong PARK ; Yonggoo KIM ; Myungshin KIM
Annals of Laboratory Medicine 2016;36(2):170-173
We report the first Far Eastern case of a Korean child with familial hemophagocytic lymphohistiocytosis (HLH) caused by a novel syntaxin 11 (STX11) mutation. A 33-month-old boy born to non-consanguineous Korean parents was admitted for intermittent fever lasting one week, pancytopenia, hepatosplenomegaly, and HLH in the bone marrow. Under the impression of HLH, genetic study revealed a novel homozygous missense mutation of STX11: c.650T>C, p.Leu217Pro. Although no large deletion or allele drop was identified, genotype analysis demonstrated that the homozygous c.650T>C may have resulted from the duplication of a maternal (unimaternal) chromosomal region and concurrent loss of the other paternal allele, likely caused by meiotic errors such as two crossover events. A cumulative study of such novel mutations and their effects on specific protein interactions may deepen the understanding of how abnormal STX1 expression results in deficient cytotoxic function.
Alleles
;
Amino Acid Sequence
;
Asian Continental Ancestry Group/*genetics
;
Base Sequence
;
Bone Marrow/metabolism
;
Child, Preschool
;
Comparative Genomic Hybridization
;
DNA Mutational Analysis
;
Genotype
;
Haplotypes
;
Homozygote
;
Humans
;
Lymphohistiocytosis, Hemophagocytic/*genetics/pathology
;
Male
;
Molecular Sequence Data
;
Mutation, Missense
;
Pedigree
;
Qa-SNARE Proteins/*genetics
;
Republic of Korea
;
Sequence Alignment